Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Medical VC (Venture Capital) Funds in Spain in November 2024

Last updated: Nov 2024 A list of 50 VC (Venture Capital) funds that invest in Medical startups based in Spain. We rank investors based on the number of investments they made in Medical companies from Spain. We update this investor list every month.

Top 50 Medical VC (Venture Capital) Funds in Spain in November 2024

Investor	Medical Spain investments
Inveready	7
Criteria Venture Tech	7
ENISA	7
CRB Inverbío	6
Capital Cell	6
Centre for the Development of Industrial Technology (CDTI)	5
SODENA	5
Ysios Capital	3
Clave Mayor	3
Bio&Tech Smart Capital	3
EASO Ventures	3
Asabys Partners	3
Gestion De Capital Riesgo Del Pais Vasco	2
Wellington Partners	2
Banco Sabadell	2
Seed Capital Bizkaia	2
Clave	2
Monte Carlo Capital	2
GENESIS Biomed	2
Medex Partners	2
Adara Ventures	2
Kereon Partners	2
Xesgalicia	2
Encomenda VC	2
ENISA	2
Ancora Finance Group	2
Speedinvest	2
Innogest Capital	2
Alta Life Sciences	2
Alma Mundi Ventures	2
AA Sons	2
MTIP AG	2
Growth Venture Partners	1
Roche Venture Fund	1
Novartis Venture Fund	1
CIMEDO	1
Akilia Partners	1
EDEM Business School	1
Corporación CAN	1
Nina Capital	1
Valencia Institute of Finance	1
Naos	1
Fides Capital	1
Omega Funds	1
UCB Ventures	1
Fitalent	1
Cabiedes & Partners	1
VitaminaK	1
Reig Jofre	1
BCN PEPTIDES	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

We are a leading asset manager in Spain. We invest in early-stage VC, growth VC, venture debt, strategic public equity, private equity and infrastructure. Our different strategies allow us to provide financing solutions to companies throughout their life-cycle.

Investment focus

Software, Biotechnology, Information Technology
Seed, Funding Round, Series A
Spain, United States, United Kingdom

Portfolio highlights

Nanusens — Nanusens shrinks MEMS sensors and builds nanoscale sensors (NEMS – Nano Electro Mechanical Systems) along with the control electronics using standard CMOS processes.
IENAI SPACE — IENAI SPACE develops efficient ionic-liquid electric propulsion systems and mission analysis for nano-satellites. The company provides propulsion modules customized for each particular platform and mission, from 2U to 12U, from RAAN-spacing to Earth-Moon transits or de-orbiting.Its versatile Tailored Taylor Thruster is highly scalable in specificimpulse and thrust. It is based on a novel iteration of electrospray thrusters, which boast high theoretical efficiencies for electric propulsion technologies in the low power range. In combination with its decreased form factor, meaning less propellant on-board, making this technology attractive in constrained volumes.IENAI SPACE was founded in 2019 and is headquartered in Madrid, Spain.
Scaleup Finance — Improve your financial management

Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Pre-Seed to Series C) managing more than €300M of AUM.

Investment focus

Software, Biotechnology, E-Commerce
Seed, Funding Round, Series A
Spain, United States, United Kingdom

Portfolio highlights

Enline — Technology for Power Systems, TRANSMISSION AND DISTRIBUTION SYSTEM OPERATORS, INDUSTRY AND MINING, ENGINEERING & CONSTRUCTION, INSURANCE AND CONSULTANCY, UTILITIES & POWER GENERATION, ENLINE MONITORING SYSTEM, ENLINE DYNAMIC LINE RATING, ENLINE FAULT LOCATION, ENLINE POWER OPTIMIZATION .
Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
KIT-AR — Reduce time and costs spent fixing errors on your manufacturing shopfloor with quality assurance and augmented reality- Click in to find how!

ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.

Investment focus

Software, Health Care, E-Commerce
Seed, Debt Financing, Pre-Seed
Spain, United States, France

Portfolio highlights

Remolon — Remolon's mission is to reduce food losses and waste while also building a better food system for all.
Ubicuity — Ubicuity is a software platform that allows to create and manage advanced audiovisual experiences for space managers and content providers.
Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.

CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies

Investment focus

Medical, Health Care, Biotechnology
Series A, Funding Round, Seed
Spain, Mexico

Portfolio highlights

Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
Biocross — Biocross, S.L., a biotechnology company, develops blood tests for the diagnosis of Alzheimer’s diseases to neurologists.
Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.

Capital Cell is a pan-European crowdinvesting platform for Biotech & Life Sciences companies. Mixing VC, business angels, accredited investors and the power of the Crowd, the company is building a global meeting point for companies and researchers working, fostering and financing tomorrow’s medical science.

Investment focus

Health Care, Biotechnology, Medical
Equity Crowdfunding, Funding Round, Seed
Spain, United States, United Kingdom

Portfolio highlights

Exheus — Exheus tells everything that you need to know to take maximum care of yourself and avoid risks to your health, exheus is much more than a DNA test that only indicates which genes you have.
MediQuo — MediQuo is a hospital in your pocket, connecting patients and professionals for any health interaction. Healthcare today has 75% of unnecessary medical visits that could be taken in the distance, and the vast majority of health professionals are using messaging platforms such as WhatsApp to communicate with patients or other health professionals.MediQuo is a chat-based app specialised in health, GDPR and health data compliant, giving professionals time control, incorporating patient medical history and phone privacy. Allowing also video and audio communication. It is a place for discussion, appointments or medical consultation with your doctor or any new health professional. Also includes immediate 24/7 medical response and a network, for health information and professional discovery. We have done already 1M consultations and got 600k app downloads. Our Google Play Ratings are 4,6 (with 6k reviews). We are amongst the top health apps in Spain and Latam.
Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer

The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .

Investment focus

Biotechnology, Health Care, Software
Funding Round, Seed, Grant
Spain, United States, France

Portfolio highlights

Tebrio — At the rate that the world is growing, we’ll only have enough food to feed 50% of our future population by 2050 and introducing novel proteins into the food value chain that are rich in amino acids and use less water and arable land is the only solution forward for mankind and the planet, which is why, in 2014, Adriana Casillas and Sabas de Diegofounded Tebrio, the world’s leading carbon-negative, zero-residue insect biotechnology company, which tackles climate change and the world food crisis by breeding and transforming rich amino acid mealworms into three main co-products: (i) sustainabe premium fish, pet and animal feed (ii) biofertilizer for plant nutrition that acts as a natural pest repellent (iii) chitosan to manufacture biodegradable plastic that disolves in water. Our carbon negative pilot farm produces 500 tons of co-products a year, does not emit greenhouse gases like ammonia or methane, uses 98% less water and 90% less arable land than other animal and plant protein farms, and is the only company in our industry in Spain that has received an ISO9001 certification, which guarantees the quality of our products. Thanks to our current operations, we have secured an undisclosed Series A round, which we are using to develop a EUR 50 million insect farm that will take us from a 500 tn to a 100.000 tns production of co-products a year and will be the largest of its kind in the world. Company Key Metrics: • Tebrio has 8 industrial patents in 150 countries • Tebrio’s operations are carbon negative, zero residue, and we do not emit greenhouse gases like ammonia or methane • With the same amount of natural resources, we are able to produce 500% more protein for fishmeal and animal feed than plant protein and livestock farms • Our protein for fish and animal feed is 90% digestible, 70% protein, high in essential amino acids and unsaturated fat • Tebrio was the first certified producer in the world of mealworm protein for fish and animal feed and biofertilizer for plant nutrition • Our tech powered biofertilizer has 10x more nutrients than other organic fertilizers and thanks to its properties, acts as a natural pest repellent • We are the only Spanish company in our industry with an ISO9001 certification • We are building the world’s largest insect farm, which will produce 100.000 tons of co-products a year for animal feed and plant fertilization • We use big data and 4.0 industries to industrially produce and control the Tenebrio Molitor insect
Zeleros — Leaders in the development of hyperloop technologies, we are your new electrification & automation partner in the mobility sector.
INBRAIN Neuroelectronics — We are scientists, doctors, techies and humanity lovers, with the mission of building neuroelectronic interfaces to cure brain disorders.

SODENA is the main instrument of the Government of Navarre for the business development of the region. SODENA carries out its activities as a public limited company, with a majority direct shareholding of 65.42% by the Government of Navarre, and an indirect participation through Nafinco (14.58%). It also participates in the shareholding of GrupoCorporativo Empresarial Caja Navarra (20%), through TME 2001 CorpCan, S.L.

Investment focus

Biotechnology, Health Care, Software
Debt Financing, Funding Round, Seed
Spain, United Kingdom

Portfolio highlights

MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
MainRail — KEY BENEFITS Reduce maintenance costs by preventing unscheduled repairs and optimizing resource allocation. Increase the capacity of your network by minimizing the risk of service unavailability thanks to
Pyroistech — Pyroistech uses spectroscopy to create custom solutions for the industrial sector. With this method, a sample is illuminated, and the amount of light reflected or transmitted through it is measured. It is useful in a variety of fields: Agri-food industry, Construction, Medicine, and Other sectors.

Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
Spain, United States, Switzerland

Portfolio highlights

ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
Engrail Therapeutics — Engrail delivers transformational therapies that improve the lives of patients with devastating neurologic, neuropsychiatric, and neurodevelopmental disorders.

Clave Mayor is a management company of closed investment entities based in Navarra.

Investment focus

Software, Biotechnology, Medical
Funding Round, Seed, Series A
Spain, Germany, United States

Portfolio highlights

MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
Predictheon — Predictive monitoring for clinicians. Real-time predictions about patient health status to personalize medical care, adjust and individualize therapy, and improve safety.

Bio&Tech Smart Capital is the alliance of researchers and entrepreneurs with Venture Capital management professionals to transfer scientific knowledge to society.

Investment focus

Medical, Internet, Real Time
Series A, Funding Round
Spain

Portfolio highlights

Oncostellae — Oncostellae is a biotechnology startup developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases.
ADNTRO Genetics — ADNTRO Genetics offers human genetics research, personalized nutrition plan, personal health, consulting and services
Zerintia HealthTech — Zerintia HealthTech is specialized in Digital Health. We work to promote the use of technology in medicine in order to make it easier for doctors to diagnose, care and attend to their patients.

Easo Ventures es una Sociedad de Capital Riesgo Vasca y Privada, cuyo objetivo es invertir en Startups y PYMES con proyectos de crecimiento.

Investment focus

Software, Manufacturing, Health Care
Seed, Funding Round, Series A
Spain

Portfolio highlights

Ingelia — Ingelia is a technology-based company specializing in R & D in the renewable energy sector. Ingelia is an SME based in Valencia (Spain) owned by multinational shareholders from Spain, Austria, England, and Italy.
Begas Motor — Begas has designed and manufactures the first engine for industrial vehicles powered 100% by LPG (Liquefied Petroleum Gas or AUTOGAS). Ability to remotorize vehicles and make them ecological with Euro VI certificate.
Trovant Technology — Trovant Technology specializes in the development of bio-based technologies for organic waste treatment and valorization, transforming this waste into bioenergy. They develop proprietary technology and tailor-made solutions, always keeping the market in mind. At the moment they are focusing on biogas upgrading and biomethane with UBI - BiologicalIntegral Biogas Upgrading.

Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.

Investment focus

Biotechnology, Medical Device, Health Care
Series A, Seed, Series B
Spain, France, Belgium

Portfolio highlights

Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
Augustine Therapeutics — Augustine, Innovative therapies for neuromuscular and neurodegenerative diseases
INBRAIN Neuroelectronics — We are scientists, doctors, techies and humanity lovers, with the mission of building neuroelectronic interfaces to cure brain disorders.

GestiÃ³n de Capital Riesgo del PaÃs Vasco SGECR, S.A. is a venture capital entity management company founded in 1985 by the Basque Government as part of the Sociedad para la PromociÃ³n y ReconversiÃ³n Industrial (SPRI), with the aim of promoting and developing venture capital activity in the Basque Country.

Investment focus

Medical, Artificial Intelligence, Medical Device
Seed, Series A, Funding Round
Spain

Portfolio highlights

H2SITE — We provide fully integrated systems to produce on-site high quality hydrogen.
InspectRail — InspectRail was established to offer high-quality information on the state of railway infrastructure, thereby enhancing its operation, management, and maintenance.
Inmedical Therapeutics — Innovation in medical needs

Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Funding Round
Germany, United States, United Kingdom

Portfolio highlights

Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
Sphingotec GmbH — Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time
CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.

Banco Sabadell is a banking group that specializes in serving small and medium enterprises. It comprises of several banks, brands, subsidiaries, and associated banks. The company was founded in 1881 and is headquartered in Alicante, Spain.

Investment focus

Software, Internet, Health Care
Seed, Debt Financing, Funding Round
Spain, United Kingdom, Israel

Portfolio highlights

MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
Elawan Energy — Elawan Energy is a vertically integrated company with a long-standing track record in developing, financing, constructing, and operating its own renewable power plants worldwide, with the goal of establishing its position as a significant global renewable Independent Power Producer. It promotes, builds, and operates wind farms around the worldleading the wind energy market. The company has 714 megawatts of operational projects, more than 460 megawatts under construction, and a development pipeline of over 10 gigawatts.
Vivira — Vivira Health Lab focuses on making physical rehab programs available to everyone.

Seed Capital de Bizkaia is a Regional Council company affiliated to Biscay Regional Council's Department of Economic Development and Innovation (Departamento de InnovaciÃ³n y PromociÃ³n EconÃ³mica de la DiputaciÃ³n Foral de Bizkaia) whose aim is to manage a Venture Capital Fund called â€œSeed Capital Bizkaia, F.C.R.â€.

Investment focus

Software, Biotechnology, Health Care
Seed, Funding Round, Series A
Spain

Portfolio highlights

Fisify — Fisify is a physical treatment clinic, that creates technologies to make people's life easier and offers the requested services as well as commercial communications.
H2SITE — We provide fully integrated systems to produce on-site high quality hydrogen.
CLCircular — CL Circular: Transforming Global Logistics with Circular Technology. Our mission is to make real-time visibility technology accessible

Clave is an investment management company.

Investment focus

Biotechnology, Health Care, Software
Seed, Series A, Funding Round
Spain, Chile, Switzerland

Portfolio highlights

MainRail — KEY BENEFITS Reduce maintenance costs by preventing unscheduled repairs and optimizing resource allocation. Increase the capacity of your network by minimizing the risk of service unavailability thanks to
Sincrolab — Descubre Sincrolab, el tratamiento digital que utiliza inteligencia artificial para mejorar los procesos cognitivos. Con eficacia validada en TDAH,...
homedoctor — Homedoctor is an online medical care app that offers medical video consultations. With Homedoctor's health robot, users can keep an eye on their own vital signs and record the information in their medical records to look for abnormalities in their internal and external organs. Specialists from Homedoctor's team in pediatrics, gynecology,internal medicine, dermatology, psychiatry, pneumonia, sports, and rehabilitation medicine, and nutrition help patients in a live video consultation while relying on the tools to provide an accurate diagnosis.

Monte Carlo Capital was founded in 2009 by former investment banker Ian Sosso, winner of the 2019 “Best European Early Stage Investor” award from EBAN, the Brussels-based European trade association for business angels representing the 30,000 European angel community with a presence in 50 countries. Monte Carlo Capital combines the best featuresof business angels and venture capital. We invest via fund and via SPVs. We have been the Lead in many of our investments and are increasing our Co-Investments with some of the world’s leading VCs. Typical investments start at pre-seed/seed and we regularly follow on to Series A & Series B rounds. Monte Carlo Capital invests across sectors, including Saas, Fintech, DeepTech and Health Care, in the US, Europe and the UK.Our solo managing partner was a former investment banker, spending most of his career in Asia and the UK. He retired about 15 years ago, and set up his own angel group. After being quite successful, he decided to launch the fund (January this year).

Investment focus

Medical Device, Financial Services, Medical
Seed, Funding Round, Series A
United States, United Kingdom, Spain

Portfolio highlights

Chaiz — Chaiz is the first digital marketplace for extended car warranties. Search, compare and buy service plans from top providers completely online.
LeaseTeq — LeaseTeq bietet Privat- sowie Unternehmenskunden das erste komplett digitale Leasingangebot.
CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.

Life sciences R&D, consulting and investment

Investment focus

Medical, Pharmaceutical, Biopharma
Seed, Pre-Seed, Funding Round
Spain

Portfolio highlights

Thytech — Thytech is a health tech company.
Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
Ownmed Innovation — Ownmed Innovation is a Medtech spin-off that emerged from the collaboration between the Fundación para la Investigación Biomédica Hospital Gregorio Marañón (FIBHGM), the Instituto Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD) and Universidad Carlos III de Madrid (UC3M). Its main objective is the development of a medical device, Ostofix®,aimed at ostomate patients, with the purpose of restoring their ability to regain control over their continence.

Medex Partners is an investment club focused on healthcare that is led by entrepreneurs and industrial companies with broad experience in the sector.

Investment focus

Medical, Health Diagnostics
Pre-Seed
Spain

Portfolio highlights

Manina Medtech — We created Seedchrony, first in class device to assess endometrial receptivity for embryo transfer, we are Manina Medtech | Boosting IVF Success

We help create a path Seed to exit, we've been there. We're experienced tech investors. We partner with founders with vision, courage and the capacity to execute.

Investment focus

Software, Information Technology, SaaS
Series A, Seed, Funding Round
Spain, United States, United Kingdom

Portfolio highlights

Cyber Guru — Cyber Guru operates as a cybersecurity awareness training platform. Cyber Guru serves to educate employees around the dangers and pitfalls of information security. The solutions use stimulating and educational learning paths to cater to those who do not hold specialist roles in the field of Cyber Security.
indigitall — Customer journey platform. With indigitall you can coordinate and automate all communication channels and create an omni-channel strategy
WIVI Vision — visual+cognitive enhancement

> smart projects

Investment focus

Health Care, Cooking, Medical
Seed, Funding Round
Spain

Portfolio highlights

Qualityfry — If you are looking for an automatic commercial deep fryer for your business, check the QualityFry ones. Check out and request a demonstration
Persei vivarium (Digital Health) — Persei vivarium is a digital health business dedicated to the creation of high-quality data collections that are based on real-word data for specific diseases. The technology facilitates the capture of clinical data from the physician’s daily clinicalpractice and from the patient based on a mobile appication for remote monitoring. This provides a more holistic view and better management of the disease. The information that is captured becomes a high-value resource that also, in a simple and easy process, generates high-quality research.
Transplant Biomedicals — Diabetes can be effectively controlled by following these best tips from Diabetes Guide. You will also get to know about the tips to manage diabetes naturally

XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.

Investment focus

Software, Biotechnology, Pharmaceutical
Seed, Funding Round, Pre-Seed
Spain, Portugal

Portfolio highlights

Envita — Envita is a social innovation start-up for the development of innovative digital solutions for organizations.
Appentra — In the software world, new technologies have recently put on the hands of companies and developers highly powerful tools which involve a leap in computing capabilities. First, heterogeneous multicore systems have become small and affordable supercomputers. Second, Artificial Intelligence, Machine Learning, Deep Learning, and big data arerevolutionizing entire economic sectors. These powerful tools were up until now only accessible to a minority of organizations with massive resources but finally they have become mainstream. However, to take advantage of these powerful capabilities, companies need to adopt the computing technologies created for years in (HPC) market, particularly parallel computing. PARALLELWARE ANALYZER is the most complete and fast software aimed to enable developers to overcome the complexity of parallel programming. Appentra is a Deep Tech global company that delivers products based on the Parallelware technology, a unique approach to static code analysis specialized in concurrency and parallelism. Our aim is to make parallel programming easier, enabling everyone to make the best use of parallel computing hardware from the multi-cores in a laptop to the fastest supercomputers.
Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.

Encomenda is a Venture Capital specialized in seed investments in technology startups. They open the door to investors and professional business angels to capitalize on their investments through collective investment vehicles. They minimize investment risks thanks to the diversification of the portfolio and preferential access to the best projectsin search of financing.

Investment focus

Software, SaaS, Financial Services
Seed, Funding Round, Pre-Seed
Spain, France, United States

Portfolio highlights

Zexel — Zexel is an influence campaign management software streamlining internal financial administrative processes between the agency and the influencer.
KomboAI — Close more deals and level up your sales game with KomboAI Learn new winning methodologies, adapt your pitch to your prospects and personalize your outreach. Start Now See Kombo in Action Free forever No credit card Over 200+ sales reps are already using KomboAI during their job Join the sales revolution today Get Insights Get
Loud Intelligence — Voi<3, crafted by Loud Intelligence, is a specialized AI tool designed for the audio media on-demand ecosystem, focusing on generating contextually relevant advertising content. It meticulously analyzes the content of audio media, understanding its themes and nuances to create advertisements that are perfectly aligned with the audio context.This ensures that the ads complement the auditory experience, enhancing engagement without the need for analyzing listener preferences. By automating the ad creation process, Voi<3 streamlines content production, allowing media companies to swiftly adapt to the content's context, which in turn helps advertisers deliver more resonant and effective campaigns, ultimately enriching the listener's experience.

European Union Agency for Network and Information Security (ENISA) founded in 2004.

Investment focus

E-Commerce, Internet, Education
Seed, Debt Financing, Grant
Spain, United States

Portfolio highlights

Cuimo — Cuimo is a motor company that offers transport, financing, and second hand motorcycle servicing.
MJN Neuroservices — MJN improves the quality of life of people suffering from epilepsy thanks to our wearable ear piece that performs an EEG of the patient. By applying AI algorithms, MJN-SERAS is able to interpret the brain signal, record epileptic seizures, objectively improve the medical monitoring and permanently assess the risk of suffering an epilepsy seizure
Recycap Technologies — Recycap Technologies develops and commercializes innovative and automated end-to-end coffee capsule recycling solutions and devices. It has created a patented platform for removing coffee grounds from coffee capsules, enabling aluminium capsules to be readily recycled.

Ancora Finance Group is an international management consulting firm that offers unparalleled leadership, strategic, and operational advice. Their focus on financial services is deeply rooted in the DNA of their company as it comes from their people. They are based in London and Singapore, providing unparalleled leadership, strategic andoperational solutions for the financial services industry. Their experience, expertise, and approach combine consulting and knowledge transfer.

Investment focus

Medical, Medical Device, Health Care
Series A
Spain, Germany

Portfolio highlights

Koa Health — Make mental health manageable, treatable, and approachable for every industry and every individual with clinical-first care designed by experts. From evidence-based self-care and prevention through clinical treatment and therapy, Koa Health supports workforce wellbeing across the continuum.
Atlas Medical Technologies — Atlas Medical Technologies is a manufacturing company that develops navigation systems for medical doctors for radiology and orthopedics.

Speedinvest is one of Europe’s most active early-stage investors, with more than €1bn AUM, 40 investors, and offices in Berlin, London, Munich, Paris, Vienna and San Francisco. Your success is our priority, so we don’t just send some money and "check in" at board meetings. Our mission is to empower you with game-changing support throughevery stage of your journey. Our focused investment teams know your industry inside and out. Their Deep Tech, Fintech, Industrial Tech, Network Effects, Digital Health and Subscriptions experience, know-how and deep networks are yours from day one. You also have full access to our in-house Platform+ team of operational experts who can provide tailored growth marketing, people (HR), US business development, and networking support throughout every stage of your journey.

Investment focus

Software, FinTech, Financial Services
Seed, Series A, Pre-Seed
Germany, United Kingdom, Austria

Portfolio highlights

autone — Autone is a SaaS operational platform enabling retail & CPG businesses to make optimal decisions easily and quickly
AllFocal Optics — AllFocal Optics revolutionizes display technology through groundbreaking nanophotonic solutions.
Recyda GmbH — All-in-one Packaging Recyclability Management

We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries

Investment focus

Health Care, Medical, Medical Device
Funding Round, Series A, Series B
Italy, United States, Spain

Portfolio highlights

GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
Renovacor — Renovacor is a preclinical‑stage biopharmaceutical company focused on developing transformative gene therapy‑based treatments for cardiovascular disease.Renovacor’s lead program is a recombinant adeno-associated virus (AAV)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associatedathanogene 3 (BAG3) gene.Dilated cardiomyopathy is a condition affecting over 3 million patients in the US and growing steadily. Many patients develop DCM due to ischemic heart disease. Recently subpopulations have been identified that develop DCM due to mutations in specific genes that have been shown to result in the development of DCM. One of these specific genes is the BAG3 gene. The prevalence of disease‑causing BAG3 haploinsufficiency is estimated at approximately 35,000 individuals in the United States, representing an orphan disease by FDA guidelines. It is estimated a similar number of DCM patients with BAG3 mutations exist in Europe. These patients are typically younger and progress to end-stage heart failure sooner than patients with ischemic heart disease. Currently, DCM patients with a BAG3 mutation are treated with standard of care for heart failure. Despite improvements in pharmacotherapy and care, the five‑year survival of a patient with DCM is only 50%. The development of a BAG3 gene replacement therapy for patients with DCM that carry BAG3 mutations could potentially prevent the progression of disease in this otherwise healthy population of young adults.
BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.

Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.

Investment focus

Biotechnology, Health Care, Medical Device
Series A, Funding Round, Seed
Spain, United States

Portfolio highlights

DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
Mediktor — Mediktor is an interactive tool that can analyse users' symptoms and evaluate their state of health. It also allows them to chat with a doctor in real time.

We back bold and purpose-driven founders.

Investment focus

Software, Insurance, InsurTech
Series A, Seed, Funding Round
Spain, United States, United Kingdom

Portfolio highlights

Raincoat — Get the policy that offers you cash after the hurricane, without deductibles or having to make claims!
Supercede — Supercede is an independent reinsurance technology company that supports, rather than disintermediates, the traditional tripartite value chain. We offer a digital ecosystem for all reinsurance industry stakeholders to let them show what they can really do, unhindered by the burden of manual admin. Our product is a powerful, Lloyd’s-recognised,data-centric, global trading platform designed specifically for the reinsurance community of cedents, brokers and reinsurers. It offers the leading outwards analytics solution, in an intuitive placement platform, with access to a global reinsurance network.Supercede supports networking and collaboration, with group chat threads, rapid file sharing, and workflow tools linked to every placement. We help optimise the reinsurance lifecycle, from capturing single-entry, actuarial-grade data, to doing the deal, to driving on-going administration. If you haven’t met us yet, come and find us on www.supercede.com. We are a team of industry experts, technologists and strategists changing reinsurance for the better, for everyone.
REVER — REVER is born to disrupt how eCommerce returns work by making them easier and faster for everyone.

AA Sons focuses on raising venture capital for ambitious, fast-growing companies with a desire to 'make the world a better place' in retail, mobility, healthcare, care, fintech and broader tech sectors.

Investment focus

Software, Information Technology, E-Commerce
Seed, Series A, Funding Round
France, United States, Israel

Portfolio highlights

HUG — Join our global creative community to showcase & sell your art, connect with others, and access creator-friendly grants and education.
Kate — Kate redefines everyday mobility by offering electric vehicles made in France.
Multiwave Technologies — More than 2/3 of humanity has no access to medical imaging Our mission is to make MRI available globally, through our ultra-low field mobile device.

MTIP is a growth capital investor that specializes in scaling up healthtech companies in rapidly expanding global markets. Visit our website!

Investment focus

Health Care, Artificial Intelligence, Medical
Series A, Series B, Series C
United States, United Kingdom, Spain

Portfolio highlights

Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.
Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.

Growth Venture Partners is a specialized middle market investment bank, with deep domain expertise that are focused primarily on private companies and its stakeholders who are seeking financing via private placements or strategic investments, as well as liquidity via the secondary market or M&A. The Firm's distinguished services are uniquein its robust network of institutional and strategic investors, as well as its capabilities of combining timely execution of transactions, creative deal structuring, complex negotiations, perceptive market insight and in-depth qualitative and quantitative analyses. Growth Venture Partners builds strong credibility with its investor and corporate clients through a commitment of delivering top tier investment banking services. As a trusted advisor, the Firm adheres to high standards and places strong emphasis on establishing long-term relationships with investor and corporate clients, originating value-add ideas that help achieve strategic objectives and maximize shareholder value, and performing world-class execution that yields timely results. Additionally, Growth Venture Partners maintains a comprehensive database of fundamental industry knowledge and framework of sectors and sub-sectors, which are used to identify forward-looking trends and drivers, track emerging companies and strategic opportunities, and originate unique ideas that help define the future of the market.

Investment focus

Medical, Health Care, Neuroscience
Funding Round
Spain

Portfolio highlights

Sincrolab — Descubre Sincrolab, el tratamiento digital que utiliza inteligencia artificial para mejorar los procesos cognitivos. Con eficacia validada en TDAH,...

The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche. Roche has allocated CHF 500 million to invest in and develop commercially successful innovative life science companies. Roche has been investing in early stage companies as part of collaborations since the early-1990s and independent ofcollaborations since 2002. All equity investments made by Roche in biotech and diagnostics companies (including collaboration investments) are negotiated and managed by the Roche Venture Fund. In the past 20 years, the Roche Venture Fund has invested in over 60 companies globally. Currently, Roche Venture Fund has a portfolio of around 30 companies located in 10 countries across Europe, North America and the Pacific Region. The fund is an evergreen fund with CHF 500 million available of which approximately 40% is currently invested.The Roche Venture Fund is a committed long-term stable investor with sufficient money reserved in their fund for follow-on financing rounds. As part of a multinational healthcare company, the Roche Venture Fund has access to considerable expertise both internally and externally. We co-invest with leading venture funds, including other corporate venture funds, on a regular basis.

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Series C
United States, United Kingdom, Spain

Portfolio highlights

DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
NMD Pharma — NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.Research by the founders working on the neuromuscular junction identified an approach that has not previously been exploited but shows great promise.Importantly, the approach improves neuromuscular transmission in a way that ispotentially applicable to a range of clinical indications and orphan human diseases that have profound unmet medical need.
Bonum Therapeutics — Bonum Therapeutics is focused on a proven technology that utilizes allosteric regulation to create targeted, highly active, and less toxic medicines.

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Series C
United States, Switzerland, United Kingdom

Portfolio highlights

Hyku — Hyku Biosciences is developing the next generation of covalent medicines by targeting histidine, tyrosine and lysine binding pockets in disease-causing proteins.
Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Hepalink — Hepalink is a manufactures ultra-pure pipeline control systems based on semiconductors and pan-semiconductor liquid circuits.

CIMEDO is a holding company with offices in Wörth and Frankfurt. They focus on corporate investments, start-ups, and real estate.They do not just own stakes in or own subsidiary companies; they also run them. Typical leadership responsibilities include the establishment of strategic business areas, strategic management, strategic control, thefilling of leadership positions, liquidity management, and cash management within the group.

Investment focus

Information Technology, B2B, Artificial Intelligence
Seed, Pre-Seed, Funding Round
Germany, United States, Spain

Portfolio highlights

delphai — More, better, faster company intelligence. Create company lists.
Bloom — Bloom empowers everyone to be their own therapist through interactive video-guided therapy sessions.
Universal Diagnostics — Universal Diagnostics S.L. (UDX) is a Spanish in-vitro diagnostics company developing a platform of minimally-invasive, blood-based solutions for detecting cancer early when treatment options are more plentiful and survival rates are still high. UDX believes that the best way to fight against cancer is by detecting it early.The UDX diagnosticplatform is designed to detect various cancer types, e.g. colorectal, liver, pancreatic, lung, and gastric cancer via one simple blood test. The assays rely on a curated set of proprietary methylation marker panels; a simple blood sample collected as part of a routine check-up, can be processed at a reference laboratory or hospital using standard equipment and then uploaded to the UDX Cloud for final algorithmic analysis.UDX’s first marker panel is a colorectal cancer screening test. The test identifies individuals who need to be referred for colonoscopy. Colorectal cancer is the 3rd most frequent cancer and 2nd deadliest cancer worldwide. The challenge is that colorectal cancer is mostly detected in late stages, with significantly decreased survival rates (11% survival rate in stage IV vs. 85% survival rate in stage I).To develop the test and execute its R&D and operations, UDX partners with international research institutions, hospitals, universities, and biobanks around the globe.

Industry Transforming Technology Investments. An investment firm born to accelerate the pace of innovation and materialize its potential to improve the world

Investment focus

Medical, Health Care, Medical Device
Series A
Spain

Portfolio highlights

Koa Health — Koa Health is here to help create better workplace wellbeing for your employees. Find out more about our digital mental health solutions.

Escuela de empresarios y negocios en Valencia. Los mejores cursos universitarios y cursos para empresarios con vistas al mar.

Investment focus

Medical, Health Care, Pharmaceutical
Seed
Spain

Portfolio highlights

YSOTOPE THERANOSTICS — YSOTOPE uses specific ligands to design co-diagnostic radiotracers to monitor CAR-T cells inside the patient’s body. YSOTOPE is a Spanish company founded in 2022 by a team with experience in deeptech entrepreneurship and radiochemistry. The loss of CAR-T in blood is a problem for oncologists making them more difficult to personalize the treatment.Molecular imaging is a non-invasive solution for providing information about CAR-T therapy to oncologists.

Corporación CAN is a company that provides manufacturer of centrifugal pumps.

Investment focus

Medical, Biotechnology
Funding Round
Spain

Portfolio highlights

ProRetina Therapeutics — ProRetina Therapeutics, S.L. operates as a biotechnology company. The company was founded in 2007 and is based in Pozuelo de Alarcon, Spain.

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Investment focus

Health Care, Artificial Intelligence, Medical
Seed, Pre-Seed, Series A
United States, United Kingdom, Austria

Portfolio highlights

basys.ai — Basys.ai automates the process of prior authorization and utilization management to improve costs and timeliness for health plans/payers using an AI-based platform. The proprietary platform automates the process of encoding/digitizing the payer policies using machine learning, thus reducing the piloting timeline by up to 9 months.
Sober Sidekick — Gamified peer to peer support
ALFIE — AI software platform that provides consistent and automated measurements from radiographic images used to assess spinal disorders.

Valencia Institute of Finance

Investment focus

Software, Artificial Intelligence, Machine Learning
Seed, Debt Financing, Funding Round
Spain

Portfolio highlights

aunoa — We are an Artificial Intelligence Software company focused on providing automation tools to improve customer experience and support
Yuvod — Create your own end to end OTT and/or IPTV platform so you can focus on acquiring customers.
Zeleros — Leaders in the development of hyperloop technologies, we are your new electrification & automation partner in the mobility sector.

Naos

Investment focus

Medical, Software, Health Care
Series A, Funding Round
Spain, France

Portfolio highlights

MYCOPHYTO — Co-created in July 2016 by Justine LIPUMA, PhD in microbiology, and Christine PONCET-DOISE, Senior Research Engineer at INRA, MYCOPHYTO is the result of 30 years of experimentation in biological crop protection.
Mediktor — Mediktor is an interactive tool that can analyse users' symptoms and evaluate their state of health. It also allows them to chat with a doctor in real time.

Fides Capital is an investment firm, specialized in seed and early stage technology-based companies with scalable B2B business models that have already achieved recurring income. We back committed and experienced teams who are capable of leading ambitious projects with international projection. But, beyond the professional abilities, for usit's essential to have a personal understanding and alignment of interests with the entrepeneurs in order to row together in the same direction. Partnering with the teams is a key pillar in Fides's investment strategy since we like to collaborate actively with them, sharing our experience and knowledge. We invest between 50,000 € and 400,000 € per deal by disbursing funds in gradual installments and we co-invest with other participants that assume the role of lead investor.Our portfolio companies are mainly in the telecom, B2B services, health, fintech and edutech sectors: - AdmInMe (www.admin-me.com) - Agile Content (www.agilecontent.com) - eGarante: (www.egarante.com) - Excom (www.excom.es) - Imegen (www.imegen.es) - Indexa Capital (www.indexacapital.com) - Joinup (www.joinuptaxi.com) - Kuaderno (www.kuaderno.com) - Masmovil (www.masmovil.es) - Next (www.gruponext.es) - Nuubo (www.nuubo.com) - Playfilm (www.playfilm.tv) - Quantyca (www.quantyca.com)

Investment focus

Software, Automotive, Telecommunications
Seed, Pre-Seed, Series A
Spain

Portfolio highlights

Devengo — Light-speed transfers. Our Instant Payments API enables seamless integration to automate payouts to your customers in Europe and the UK.
CHECKTOBUILD — Compare automatically the reality of your construction inspection with the BIM Model and get an accurate as-built analysis.
Energy Solar Tech — Energy Solar Tech is a solar energy technology company.

We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Series C
United States, Switzerland, United Kingdom

Portfolio highlights

ARTBIO — ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines. ARTBIO is changing cancer care by creating a new class of alpha radioligand therapeutics (ART) and the ecosystem that supports.
Upstream Bio — Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma. Upstream Bio was founded in 2004 and was headquartered in the United States.
Bicara Therapeutics — Bicara enables access to the thriving innovation ecosystem which accelerates our development of therapies for cancer. Synergies between the Bicara teams in Boston and Bengaluru will pioneer breakthrough innovation.

UCB Ventures is a €150 million strategic corporate venture fund

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Funding Round
United States, Belgium, Spain

Portfolio highlights

Splice Bio — We are working with our proprietary platform to address key limitations of current gene therapy approaches to treat patients in need.
Switch Therapeutics — Switch Therapeutics is a biotech company dedicated to revolutionizing RNA interference (RNAi) therapies with conditionally activated siRNAs (CASi).
Code Biotherapeutics — Code Biotherapeutics is an emerging next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases not well served by other gene therapy technologies.

Fitalent (FIT Investment Talent SCR Simplified Regime SL) is a venture capital firm formed in early 2011 and registered in the special register of the National Securities Market Commission (CNMV), which invests in technology companies and proven successful products , whose main asset are people and talent .Their mission is to assistentrepreneurs to get consolidated, profitable and leading companies in the technology market segment. They want to be financial and strategic partners of the companies in which they participate.

Investment focus

Biotechnology, Analytics, Artificial Intelligence
Seed, Funding Round, Series A
Spain

Portfolio highlights

Citibeats — Citibeats uses AI and cutting-edge technology to transform ethically sourced public opinions into real-time, data-driven actionable insights. Monitor trends surrounding sustainability, social risk, and more.
Boxmotions — Home delivery of bulky items (furniture, home appliances, large sports equipment, etc.) is a large, growing, segregated and underserved market. Retail and e-commerce are in need of a solution that delivers quality and end customer experience standards comparable to the most innovative regular parcel delivery solutions.Boxmotions' owntechnology stack and operational processes have been meticulously curated with an end-customer-centric approach, generating capabilities unseen in the bulky items logistics industry before: scheduled time slot deliveries controlled by the end customer, delivery times x5 faster than industry average, tailored technology-guided interactions, assembly/dissassembly services, and more. We connect demand's orders with a curated pool of existing, segregated supply while guiding the whole value chain through our technology and generating incremental operational efficiency. Such model entices supply and, at the same time, provides retail and e-commerce with a capability to boost end customer experience with only competitive logistics costs.The basis of our technology stack and supply curation comes originally from an initial business line: an on-demand-storage solution for personal logistics. In our journey towards a larger market, we have always maintained our vision of making urban life easier, and more sustainable.
Oncostellae — Oncostellae is a biotechnology startup developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases.

Cabiedes & Partners is a Spanish venture capital firm that provides seed funding and early-stage and later-stage investment services. Cabiedes & Partners was founded in 2009 and is headquartered in Madrid, Spain.

Investment focus

E-Commerce, Internet, Fashion
Seed, Series A, Funding Round
Spain, France, United Kingdom

Portfolio highlights

Shalion — Shalion provides eCommerce data solutions to help global brands like Heineken, Kellogg's, AB Inveb, ISDIN, Revlon, Wella or Hasbro.Beyond traditional Digital Shelf analytics, Shalion has started a true revolution with an integrated solution that helps brands measure the success of their overall online Visibility and eRetail Media. This toolhelps to monitor all types of retail Ads, Search results (organic or paid), their share of shelf, and promotional activity across the top retailer sites worldwide. The experienced team allows Shalion to adapt fast to the evolving eCommerce landscape and that’s why innovative solutions to monitor Q-Commerce Apps and our Amazon Market Share solution have been also launched recently.
Tuio — Tuio is a insurance company that provides digital platform providing house or propety insurance.
GoTrendier — Gotrendier.com.co is a platform to sell the clothes that you no longer use and to buy in the closet of other girls throughout Colombia. Posting your products on gotrendier.com.co is completely free! They are sure that in your closet you have many fashion garments that you have not even put on, or that are new, even with a label. At GoTrendier wegive you the opportunity to sell these items and earn money. In addition, you can buy clothes from other users, and find your new favorites

Vitamin K is an SCR that invests in technology companies and internet in its early stages. They invest in entrepreneurs with experience and equipment, providing funding and support to the management.

Investment focus

E-Commerce, Health Care, Software
Seed, Funding Round, Angel
Spain, United States

Portfolio highlights

MailTrack — MailTrack is a SaaS which takes the double-checks from mobile messaging to the email.So far, MailTrack is available only as an extension for Google Chrome and Gmail.MailTrack was an initiative of Nacho González (creator of InfoJobs.net). Partners include Daniel Giménez (CTO/founder Trovit.com), Jesús Monleón (co-founder Offerum.com),David Tomás (founder CyberClick) and Eduardo Manchón (founder Panoramio, recently sold to Google).Founders include Gabi García and Gil Casadevall.
iContainers — Instant ocean freight rates for FCL and LCL shipping. Compare thousands of prices and book in seconds. Book, manage, and track your shipments online.
PromoFarma.com — PromoFarma.com is the leading online marketplace of consumer health and wellness products, enabling thousands of customers to purchase the best beauty, baby and health products directly from hundreds of pharmacies and other health merchants. Founded in Barcelona, PromoFarma.com is operating in Spain, but it's already planning to export itssuccessful business model abroad.The company's innovative model is based on Spanish high retail pharmacies for a quick and profitable delivery of quality products from the most renowned brands. It is a new business model that combines online sales of consumer health products with the added value of their delivery from the local pharmacy channel. This marketplace enables users to order online and receive products at home with trust, transparency and convenience guaranteed.The company bases its value proposal on a wide catalog of 30.000 items, the best prices and an excellent delivery service. Currently, PromoFarma.com has a network of 300 pharmacies across Spain and more than 150.000 buyers, getting strong brand recognition thanks for its TV campaigns.PromoFarma.com is transforming the online health challenge into a marketplace that provides confidence to consumers who are interested in healthcare products with the highest pharmaceutical features.PromoFarma.com has been recognized by the magazine Actualidad Económica as one of the Best Spanish Startups for its innovation, talent and youth. Furthermore, in 2014 and 2015 it has been awarded with the popular prize of “Best Beauty and Personal Care Webshop”.